Compare Royalty Pharma plc Class A Ordinary Shares (RPRX) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royalty Pharma plc Class A Ordinary Shares vs Vanguard Total Stock Market Index Fund ETF — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.52 (market cap $25.27B), while Vanguard Total Stock Market Index Fund ETF trades at $380.44 (market cap $2.30T). The key difference: Vanguard Total Stock Market Index Fund ETF is far larger — about 91× Royalty Pharma plc Class A Ordinary Shares's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Vanguard Total Stock Market Index Fund ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Vanguard Total Stock Market Index Fund ETF for 131 Days on average.
| RPRX | VTI | |
|---|---|---|
Market Cap | $25.27B | $2.30T |
Volume | 3,671,183 | 2,982,924 |
Sector | Health | — |
52-Week High | $63.96 | $384.30 |
52-Week Low | $35.44 | $311.68 |
Typical Hold Time | 0 Days | 131 Days |
Enterprise Value | $32.50B | — |
Dividend Yield | 1.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VTI trades at $381.03, down 0.39% on the day, with bullish technical signals from moving averages. The ETF maintains broad exposure to the entire U.S. equity market with over 3,500 holdings. Recent news highlights strong long-term performance potential, with $500 monthly investments since 2001 growing to approximately $876,000 according to The Motley Fool (2026-10-01).
VTI offers diversified U.S. stock market exposure with low expense ratios, making it suitable for long-term investors. Key risks include concentration in top holdings and market volatility. Analyst sentiment remains positive for buy-and-hold strategies, though current RSI levels suggest potential near-term consolidation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →
